Archives

by in
Entry Author Date Location
Genentech, ImmunoGen Win FDA OK for Souped-Up Breast Cancer Drug 02/22/13 San Francisco
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
Seattle Genetics Gets $25M in Broader Abbott Deal 10/23/12 Seattle
Genentech, ImmunoGen Souped-Up Breast Cancer Drug Extends Lives 10/01/12 San Francisco
Genentech, ImmunoGen Breast Cancer Drug Extends Lives 08/27/12 San Francisco
ImmunoGen Emerges from Genentech’s Shadow With Novel Cancer Drugs 07/12/12 Boston
Igenica Pulls in $33M to Fight Cancer With Antibodies 06/12/12 San Francisco
ASCO Wrap-Up: A Summary of This Week’s Cancer R&D Headlines 06/05/12 National
Genentech, ImmunoGen ‘Smart Bomb’ for Breast Cancer Blazes New Trail 06/03/12 San Francisco
Genentech, Roche Find New Balance Three Years Post-Merger 05/29/12 San Francisco
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies 05/16/12 National
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show 05/14/12 National
Adimab, ImmunoGen, OvaScience, & More Boston Life Sciences News 04/06/12 Boston
Genentech, ImmunoGen ‘Smart Bomb’ for Breast Cancer Clears Big Hurdle 03/30/12 San Francisco
Genentech Looks to Turn the Page at Breast Cancer Confab 12/01/11 San Francisco
Genentech, ImmunoGen’s Souped-Up Antibody for Breast Cancer Passes Key Test 09/24/11 San Francisco
Cyterix Develops New Twist on an Old Idea, With ‘Smart Bomb’ Cancer Drugs 06/22/11 San Francisco
Sutro Biopharma Grabs $36.5M in Venture Deal to Make “Biobetters” 11/17/10 San Francisco
Exelixis Gets $60M from Bristol, Genentech Surpasses Original Herceptin, Synosia Pockets $30M, & More Bay Area Life Sciences News 10/15/10 San Francisco
ImmunoGen Gets $45M Upfront From Novartis To Make Souped Up Antibodies For Cancer 10/11/10 Boston
Genentech’s Souped-Up Breast Cancer Drug Beats Original Herceptin in Head-to-Head Study 10/08/10 San Francisco
ImmunoGen and Genentech “Empowered Antibody” Cancer Drug Fails to Garner Accelerated Approval from FDA 08/27/10 Boston
Genentech Agrees to Pay Seattle Genetics Up to $900M for “Empowered Antibodies” 08/03/10 Seattle
Corey Goodman’s New Startup, UCSF Spinoff Raises $40M, Gail Maderis Gives Back, & More Bay Area Life Sciences News 07/09/10 San Francisco
Genentech Seeks FDA Nod for T-DM1 07/07/10 San Francisco
Genentech’s Souped-Up Antibody, Reg Kelly’s Mission, LS9 Nears Moment of Truth & More Bay Area Life Sciences News 06/25/10 San Francisco
Genentech’s Souped-Up Herceptin: The Odyssey Toward a More Powerful Breast Cancer Drug 06/14/10 San Francisco
Seattle Genetics, Growing Up in a Hurry With Millennium, Aims to Make Most of Cancer Drug 05/26/10 Seattle
Seattle Genetics Maps Out a Future With Antibody Drugs That Are “Empowered” 01/06/10 Seattle
Ambrx, Saying Thanks to its Rivals, Rides Wave of Interest in “Empowered” Antibodies 01/06/10 San Diego
Page 1 of 2 next page »